Haidar, Ahmad
Lovblom, Leif Erik
Cardinez, Nancy
Gouchie-Provencher, Nikita
Orszag, Andrej
Tsoukas, Michael A.
Falappa, C. Marcelo
Jafar, Adnan
Ghanbari, Milad
Eldelekli, Devrim
Rutkowski, Joanna
Yale, Jean-François http://orcid.org/0000-0002-7833-9050
Perkins, Bruce A. http://orcid.org/0000-0002-5885-0046
Funding for this research was provided by:
JDRF (4-PAR-2017-327-A-N)
Gouvernement du Canada | Canadian Institutes of Health Research (4-PAR-2017-327-A-N)
Article History
Received: 21 September 2021
Accepted: 28 March 2022
First Online: 12 May 2022
Competing interests
: A.H. received research support/consulting fees from Eli Lilly, Medtronic, AgaMatrix, Tandem, Adocia and Dexcom, and has pending patents in the artificial pancreas area. M.A.T. received research support from AgaMatrix, consulting fees from Sanofi and speaker honoraria from Eli Lilly, Novo Nordisk, Boehringer Ingelheim, Janssen and AstraZeneca. J.-F.Y. received research support from Sanofi, Bayer and Novo Nordisk, and consulting fees and speaker honoraria from Sanofi, Eli Lilly, Novo Nordisk, Boehringer Ingelheim, Janssen, Takeda, Abbott, Merck and AstraZeneca. B.A.P. received speaker honoraria from Abbott, Medtronic, Insulet and Novo Nordisk, research support to his research institute from Boehringer Ingelheim and the Bank of Montreal, and has served as a consultant to Boehringer Ingelheim, Abbott and Novo Nordisk. N.C. has received speaker honoraria from AstraZeneca and consultation fees from Novo Nordisk and Antibody Research Corporation. L.E.L. received support from a CIHR Canada Graduate Scholarship Doctoral Award. The other authors declare no competing interests.
Free to read: This content has been made available to all.